JUBLPHARMA -  India Stock  

INR 625.15  5.20  0.82%

The current JUBILANT PHARMOVA LTD price slip may raise some interest from investors. The stock closed today at a share price of 625.15 on very low momentum in trading volume. The company directors and management were unable to exploit market volatilities in September. However, diversifying your overall positions with JUBILANT PHARMOVA can protect your principal portfolio during market swings. The stock standard deviation of daily returns for 90 days investing horizon is currently 1.9. The below-average Stock volatility is a good sign for longer-term investment options and for buy-and-hold investors.
Please see Risk vs Return Analysis.

JUBILANT Stock Analysis 

The JUBILANT PHARMOVA stock analysis report makes it easy to digest most publicly released information about JUBILANT PHARMOVA and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. JUBILANT Stock analysis module also helps to analyze the JUBILANT PHARMOVA price relationship with some important fundamental indicators such as market cap and management efficiency.

JUBILANT Stock Analysis Notes

About 59.0% of the company shares are held by company insiders. The company has price-to-book ratio of 1.64. Some equities with similar Price to Book (P/B) outperform the market in the long run. JUBILANT PHARMOVA LTD recorded earning per share (EPS) of 55.4. The entity next dividend is scheduled to be issued on the 5th of August 2021. The firm had a split on the 25th of November 2010. Jubilant Pharmova Limited operates as an integrated pharmaceutical company worldwide. The company was incorporated in 1978 and is based in Noida, India. JUBILANT PHARMOVA operates under Drug ManufacturersSpecialty Generic classification in India and is traded on National Stock Exchange of India. It employs 5800 people. To learn more about JUBILANT PHARMOVA LTD call the company at 91 12 0436 1000 or check out http://www.jubilantpharmova.com.


Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. JUBILANT PHARMOVA's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding JUBILANT PHARMOVA LTD or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
JUBILANT PHARMOVA generated a negative expected return over the last 90 days
About 59.0% of the company shares are held by company insiders

JUBILANT Market Capitalization

The company currently falls under 'Large-Cap' category with current market capitalization of 97.67 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate JUBILANT PHARMOVA's market, we take the total number of its shares issued and multiply it by JUBILANT PHARMOVA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

JUBILANT Profitablity

JUBILANT PHARMOVA's profitability indicators refer to fundamental financial ratios that showcase JUBILANT PHARMOVA's ability to generate income relative to its revenue or operating costs. If, let's say, JUBILANT PHARMOVA is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, JUBILANT PHARMOVA's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of JUBILANT PHARMOVA's profitability requires more research than a typical breakdown of JUBILANT PHARMOVA's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 13.81 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 18.81 %, which suggests for every 100 dollars of sales, it generated a net operating income of 0.19.

Management Efficiency

JUBILANT PHARMOVA management efficiency ratios could be used to measure how well jubilant pharmova ltd manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 16th of October 2021, JUBILANT PHARMOVA owns the market risk adjusted performance of (3.17). JUBILANT PHARMOVA LTD technical analysis makes it possible for you to employ past data patterns with the intention to determine a pattern that calculates the direction of the firm's future prices. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume patterns, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for JUBILANT PHARMOVA, which can be compared to its peers in the sector. Please check out JUBILANT PHARMOVA LTD standard deviation, as well as the relationship between the maximum drawdown and expected short fall to decide if JUBILANT PHARMOVA LTD is priced some-what accurately, providing market reflects its prevailing price of 625.15 per share.

JUBILANT PHARMOVA LTD Price Movement Analysis

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Exponential Moving Average is calculated by weighting recent values of JUBILANT PHARMOVA LTD more heavily than older values. View also all equity analysis or get more info about exponential moving average overlap studies indicator.

JUBILANT PHARMOVA Technical and Predictive Indicators


JUBILANT PHARMOVA time-series forecasting models is one of many JUBILANT PHARMOVA's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary JUBILANT PHARMOVA's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About JUBILANT Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how JUBILANT PHARMOVA stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling JUBILANT shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as JUBILANT PHARMOVA. By using and applying JUBILANT Stock analysis, traders can create a robust methodology for identifying JUBILANT entry and exit points for their positions.
Jubilant Pharmova Limited operates as an integrated pharmaceutical company worldwide. The company was incorporated in 1978 and is based in Noida, India. JUBILANT PHARMOVA operates under Drug ManufacturersSpecialty Generic classification in India and is traded on National Stock Exchange of India. It employs 5800 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding JUBILANT PHARMOVA to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Idea Analyzer Now


Idea Analyzer

Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
All  Next Launch Module
Please see Risk vs Return Analysis. Note that the JUBILANT PHARMOVA LTD information on this page should be used as a complementary analysis to other JUBILANT PHARMOVA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Tools for JUBILANT Stock

When running JUBILANT PHARMOVA LTD price analysis, check to measure JUBILANT PHARMOVA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy JUBILANT PHARMOVA is operating at the current time. Most of JUBILANT PHARMOVA's value examination focuses on studying past and present price action to predict the probability of JUBILANT PHARMOVA's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move JUBILANT PHARMOVA's price. Additionally, you may evaluate how the addition of JUBILANT PHARMOVA to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Transaction History
View history of all your transactions and understand their impact on performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
CEO Directory
Screen CEOs from public companies around the world
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance